Scanning laser polarimetry determined retinal nerve fibre layer thickness Baseline, 6 and 12 months [clinicaltrials_resource:a6daa2306eee08ab71e8821b7cd4745b]
The primary outcome will be difference in retinal nerve fibre thickness at 6 months between affected eye and non-affected fellow eye at baseline between the amiloride and placebo group.
An additional measure will be made at 12 months
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Scanning laser polarimetry determined retinal nerve fibre layer thickness Baseline, 6 and 12 months [clinicaltrials_resource:a6daa2306eee08ab71e8821b7cd4745b]
The primary outcome will be difference in retinal nerve fibre thickness at 6 months between affected eye and non-affected fellow eye at baseline between the amiloride and placebo group.
An additional measure will be made at 12 months
Bio2RDF identifier
a6daa2306eee08ab71e8821b7cd4745b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a6daa2306eee08ab71e8821b7cd4745b
measure [clinicaltrials_vocabulary:measure]
Scanning laser polarimetry determined retinal nerve fibre layer thickness
time frame [clinicaltrials_vocabulary:time-frame]
Baseline, 6 and 12 months
description
The primary outcome will be di ...... sure will be made at 12 months
identifier
clinicaltrials_resource:a6daa2306eee08ab71e8821b7cd4745b
title
Scanning laser polarimetry det ...... ness Baseline, 6 and 12 months
@en
type
label
Scanning laser polarimetry det ...... aa2306eee08ab71e8821b7cd4745b]
@en